Provention Bio

Provention Bio is a biotechnology company focused on developing medicines to prevent or delay the onset of autoimmune diseases, such as type 1 diabetes and celiac disease. They aim to identify at-risk individuals through early detection and provide therapies that stop or slow disease development before symptoms appear. By targeting the underlying immune system responses, Provention’s approach is proactive, focusing on prevention and early intervention rather than just treating symptoms, with the goal of improving long-term health outcomes for patients.